Market Closed -
Nasdaq
04:00:00 2024-04-30 pm EDT
|
5-day change
|
1st Jan Change
|
3.96
USD
|
-2.70%
|
|
-8.12%
|
-24.86%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
861.3
|
161.7
|
331.8
|
252.8
|
-
|
-
|
Enterprise Value (EV)
1 |
1,175
|
547.9
|
331.8
|
580.9
|
525.5
|
461.2
|
P/E ratio
|
34
x
|
-1.01
x
|
-2.12
x
|
-8
x
|
-14.4
x
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2
x
|
0.32
x
|
0.65
x
|
0.48
x
|
0.45
x
|
0.43
x
|
EV / Revenue
|
2.73
x
|
1.07
x
|
0.65
x
|
1.1
x
|
0.93
x
|
0.78
x
|
EV / EBITDA
|
14.5
x
|
8.26
x
|
3.73
x
|
6.35
x
|
5.47
x
|
4.91
x
|
EV / FCF
|
75.2
x
|
-23.2
x
|
-
|
12.1
x
|
9.93
x
|
5.49
x
|
FCF Yield
|
1.33%
|
-4.3%
|
-
|
8.26%
|
10.1%
|
18.2%
|
Price to Book
|
2.38
x
|
0.64
x
|
-
|
1.12
x
|
1.01
x
|
0.89
x
|
Nbr of stocks (in thousands)
|
59,438
|
61,952
|
62,966
|
63,828
|
-
|
-
|
Reference price
2 |
14.49
|
2.610
|
5.270
|
3.960
|
3.960
|
3.960
|
Announcement Date
|
3/10/22
|
3/31/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
340.1
|
321.2
|
430.9
|
512.1
|
512.3
|
528.1
|
562.1
|
588.4
|
EBITDA
1 |
-
|
72.44
|
80.76
|
66.31
|
88.86
|
91.53
|
96.03
|
94
|
EBIT
1 |
31.19
|
58.61
|
85.36
|
47.95
|
81.05
|
78.48
|
87.82
|
-
|
Operating Margin
|
9.17%
|
18.25%
|
19.81%
|
9.36%
|
15.82%
|
14.86%
|
15.63%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
15.91
|
7.62
|
-263.9
|
-121.1
|
-30.91
|
-17.14
|
-
|
Net income
1 |
-
|
4.383
|
19.38
|
-158.7
|
-156.2
|
-47.3
|
-32.4
|
-
|
Net margin
|
-
|
1.36%
|
4.5%
|
-30.99%
|
-30.49%
|
-8.96%
|
-5.76%
|
-
|
EPS
2 |
-
|
0.8900
|
0.4261
|
-2.590
|
-2.490
|
-0.4950
|
-0.2750
|
-
|
Free Cash Flow
1 |
-
|
67.71
|
15.62
|
-23.58
|
-
|
48
|
52.9
|
84
|
FCF margin
|
-
|
21.08%
|
3.63%
|
-4.6%
|
-
|
9.09%
|
9.41%
|
14.28%
|
FCF Conversion (EBITDA)
|
-
|
93.46%
|
19.34%
|
-
|
-
|
52.44%
|
55.09%
|
89.36%
|
FCF Conversion (Net income)
|
-
|
1,544.74%
|
80.62%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/6/20
|
3/25/21
|
3/10/22
|
3/31/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
108.9
|
130.4
|
117.3
|
140.3
|
137.1
|
125.8
|
119.1
|
137.1
|
120.8
|
135.4
|
118.4
|
133.9
|
131.1
|
144.9
|
126.4
|
EBITDA
1 |
21.32
|
28.49
|
7.111
|
22.93
|
22.66
|
15.23
|
16.95
|
28.16
|
21.74
|
22.02
|
12.94
|
25.65
|
22.81
|
29.63
|
16.7
|
EBIT
1 |
15.05
|
22.29
|
1.92
|
18.32
|
17.55
|
11.79
|
13.52
|
27.6
|
20.4
|
19.53
|
11.99
|
20.1
|
19.3
|
27.1
|
13.7
|
Operating Margin
|
13.82%
|
17.09%
|
1.64%
|
13.05%
|
12.8%
|
9.37%
|
11.35%
|
20.14%
|
16.88%
|
14.42%
|
10.13%
|
15.01%
|
14.72%
|
18.7%
|
10.84%
|
Earnings before Tax (EBT)
1 |
-3.151
|
-4.618
|
-19.94
|
-6.77
|
3.184
|
-49.71
|
-100.2
|
-6.49
|
-8.191
|
-8.406
|
-15.54
|
-7.461
|
-7.91
|
-0.002
|
-16.9
|
Net income
1 |
-1.071
|
-
|
-11.28
|
-
|
-
|
-
|
-174.4
|
-3.681
|
-7.303
|
-6.096
|
-22
|
-10.2
|
-11.2
|
-3.9
|
-16.9
|
Net margin
|
-0.98%
|
-
|
-9.61%
|
-
|
-
|
-
|
-146.52%
|
-2.69%
|
-6.05%
|
-4.5%
|
-18.58%
|
-7.62%
|
-8.54%
|
-2.69%
|
-13.37%
|
EPS
2 |
-0.0300
|
-0.0100
|
-0.1900
|
-0.1100
|
0.0300
|
-0.5200
|
-2.240
|
-0.0700
|
-0.1200
|
-0.1000
|
-0.2500
|
-0.1200
|
-0.1250
|
-
|
-0.2600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/9/21
|
3/10/22
|
5/10/22
|
8/11/22
|
11/8/22
|
3/31/23
|
5/16/23
|
8/8/23
|
11/7/23
|
3/12/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
102
|
314
|
386
|
-
|
328
|
273
|
208
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.402
x
|
3.885
x
|
5.825
x
|
-
|
3.585
x
|
2.84
x
|
2.218
x
|
Free Cash Flow
1 |
-
|
67.7
|
15.6
|
-23.6
|
-
|
48
|
52.9
|
84
|
ROE (net income / shareholders' equity)
|
-
|
26%
|
22.3%
|
1.9%
|
-
|
4.64%
|
10.9%
|
12.9%
|
ROA (Net income/ Total Assets)
|
-
|
7.67%
|
7.8%
|
0.57%
|
-
|
1.28%
|
3.2%
|
4.15%
|
Assets
1 |
-
|
57.18
|
248.3
|
-27,974
|
-
|
-3,704
|
-1,014
|
-
|
Book Value Per Share
2 |
-
|
2.500
|
6.090
|
4.070
|
-
|
3.520
|
3.920
|
4.450
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
4.09
|
7.37
|
10
|
-
|
8
|
8
|
8
|
Capex / Sales
|
-
|
1.27%
|
1.71%
|
1.96%
|
-
|
1.51%
|
1.42%
|
1.36%
|
Announcement Date
|
10/6/20
|
3/25/21
|
3/10/22
|
3/31/23
|
3/12/24
|
-
|
-
|
-
|
Last Close Price
3.96
USD Average target price
8
USD Spread / Average Target +102.02% Consensus |
1st Jan change
|
Capi.
|
---|
| -24.86% | 260M | | +73.27% | 12.36B | | -21.89% | 7.83B | | +14.67% | 7.21B | | +4.77% | 5.97B | | +11.77% | 5.14B | | +29.65% | 4.43B | | -19.42% | 3.9B | | -42.48% | 2.2B | | +1.24% | 2.02B |
Medical Equipment
|